logo
Alarming number of women's shampoos, lotions and body soap found to have this cancer-causing chemical

Alarming number of women's shampoos, lotions and body soap found to have this cancer-causing chemical

Yahoo10-05-2025
A new study has found that an alarming number of personal care products contain a known carcinogen.
Formaldehyde has been linked to cancer — but the chemical, and preservatives that release it, are often added to personal care products to extend their shelf life.
And new research found this chemical lurking in items like shampoo, lotions, body soap and eyelash glue.
In recent years, the conversation about formaldehyde exposure has largely focused on hair relaxers.
Boston University researchers found that postmenopausal black women who used relaxers most often had a greater than 50% increased risk of uterine cancer compared to those who never or seldom used them.
This new study shows that the problem extends even further.
'We found that this isn't just about hair straighteners,' says lead author Dr. Robin Dodson, an exposure scientist at Silent Spring Institute. 'These chemicals are in products we use all the time, all over our bodies. Repeated exposures like these can add up and cause serious harm.'
The study, published in Environmental Science & Technology Letters, had black and Latina women log their product use for about a week, sharing photos of the ingredient labels.
The team team analyzed over 1,100 product ingredient lists looking for formaldehyde and formaldehyde-releasing preservatives.
Fifty-three percent of participants reported using at least one personal care product that listed formaldehyde releasers on its label. What's more troubling is that study participants applied many of these products daily or multiple times per week.
Researchers found DMDM hydantoin to be the most common formaldehyde-releasing preservative, with roughly 47% of skincare products and 58% of hair products with formaldehyde-releasing preservatives containing DMDM hydantoin.
However, as Dodson notes, this list is not definitive.
'Those are just the ones we knew to look for. There could be more that we're not aware of,' she said.
This research was part of the larger Taking Stock Study, a collaboration between Occidental College, Black Women for Wellness, Silent Spring and Columbia University that investigates how exposures to chemicals in beauty products contribute to health inequities for black women and Latinas in California.
While many women have learned to avoid beauty products with formaldehyde on the label, many are uninformed about formaldehyde releasers.
'We're trying to do the right thing. But there needs to be more government oversight. We shouldn't have to be chemists to figure out what kinds of products will make us sick,' said Janette Robinson Flint, executive director of Black Women for Wellness.
Dodson agrees that it is challenging for consumers to identify formaldehyde-releasing preservatives, as 'They have long, weird, funny names, and they typically don't have the word formaldehyde in them.'
Silent Spring's website contains tips on how to avoid formaldehyde releasers and an app called Detox Me that is designed to help consumers choose safer alternatives.
To reduce exposure, Dodson believes companies should be required, as they are in Europe, to add warning labels to products that contain formaldehyde-releasing preservatives.
Better than a warning, says Dodson, would be an outright ban. 'Ideally, companies shouldn't be putting these chemicals in products in the first place.'
Dodson and her research team encourage consumers to advocate for better, safer legislation.
In kind, the European Union and at least 10 US states have banned or proposed to ban formaldehyde and formaldehyde releasers in personal care products.
In 2023, the Food and Drug Administration proposed a national ban on formaldehyde and formaldehyde releasers in hair straighteners, but it has yet to be enacted.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA official returns to agency after Loomer-led ouster
FDA official returns to agency after Loomer-led ouster

CNN

time15 minutes ago

  • CNN

FDA official returns to agency after Loomer-led ouster

Federal agencies ActivismFacebookTweetLink Follow Dr. Vinay Prasad, a controversial critic of the US Food and Drug Administration who took a top role at the regulatory agency in May, has returned to his job weeks after resigning amid pressure from the White House and right-wing activist Laura Loomer. 'At the FDA's request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' said Health and Human Services spokesperson Andrew Nixon in a statement to CNN on Saturday. Nixon did not respond to CNN's inquiry about whether Prasad will also return to his role as FDA chief medical and scientific officer. In late July, Prasad, a hematologist oncologist, said he was resigning because he 'did not want to be a distraction to the great work of the FDA' and had 'decided to return to California and spend more time with his family.' Prasad's departure came amid fresh pressure from the White House for him to resign, according to a person familiar with the matter who was granted anonymity to describe the internal dynamics, and followed days of criticism from Loomer, who has extraordinary access to President Donald Trump. Loomer had taken shots at Prasad on her website and on social media, attacking him publicly for days as a 'progressive leftist saboteur' who was 'undermining President Trump's FDA.' Loomer focused on Prasad's previous social media posts and podcast episodes, where she said he aligned himself politically with liberal politicians and expressed 'disdain' for Trump. Her posts were followed by others from figures including former US Sen. Rick Santorum, who called Prasad 'the man destroying @POTUS legacy for helping patients,' and a Wall Street Journal opinion piece headlined, 'Vinay Prasad Is a Bernie Sanders Acolyte in MAHA Drag.' Prasad had been a vocal critic of some of the agency's drug approvals, as well as the government's response and vaccine policies during the Covid-19 pandemic. Loomer, reacting to the news of Prasad's return in a Saturday post on X, called it an 'egregious personnel decision' and said she planned to '(ramp) up my exposes of officials within HHS and FDA' in the coming weeks. Prasad also drew criticism from former officials and vaccine experts after internal memos from May revealed that he overrode FDA scientists on recommendations for two new versions of Covid-19 vaccines. The then-CBER director rebuked recommendations for broad use of the shots; the FDA eventually approved the vaccines for use in older and immunocompromised people but did not advise them for younger Americans who don't have underlying conditions. CNN's Meg Tirrell, Sarah Owermohle, and Adam Cancryn contributed to this report.

4 space station fliers return to Earth with Pacific Ocean splashdown
4 space station fliers return to Earth with Pacific Ocean splashdown

CBS News

time18 minutes ago

  • CBS News

4 space station fliers return to Earth with Pacific Ocean splashdown

Two NASA astronauts, a Japanese flier and a Russian cosmonaut plunged back to Earth on Saturday, safely splashing down in the Pacific Ocean, west of San Diego, to wrap up a five-month mission to space. Strapped into SpaceX's Crew Dragon Endurance, commander Anne McClain, pilot Nichole Ayers, Japanese astronaut Takuya Onishi and cosmonaut Kirill Peskov gently splashed down at 11:33 a.m. EDT, 17-and-a-half hours after undocking from the International Space Station. SpaceX support crews deployed near the landing site quickly converged on the capsule to rig the craft for a lift onto the deck of a recovery ship. After hatch opening, the station fliers were helped out of the spacecraft for initial medical checks while they began readjusting to the unfamiliar pull of gravity after 148 days in space. All four appeared healthy and in good spirits. A helicopter was standing by to fly all four back to shore, where a NASA plane was waiting to fly them back to the Johnson Space Center in Houston. The Crew 10 fliers undocked from the station's forward port at 6:15 p.m. Friday, two days later than originally planned due to high winds off the southern California coast. After moving a safe distance away from the lab complex, McClain and company enjoyed a few final hours in space before their ship was lined up for a southwest-to-northeast trajectory toward San Diego. At 10:39 a.m., the Crew Dragon's forward Draco thrusters ignited and fired for more than 17 minutes to slow the craft by about 257 mph, just enough to drop the orbit into the discernible atmosphere about 43 minutes later. Still moving at some 17,000 mph — nearly 84 football fields per second — the Crew Dragon slammed into the discernible atmosphere and was quickly engulfed in a fireball of atmospheric friction as it sharply decelerated to more terrestrial velocities. Nearing the ocean, the spacecraft's main parachutes unfurled and inflated, lowering Endeavour to a gentle splashdown. Left behind in orbit were the crew's replacements, Crew 11 commander Zena Cardman, co-pilot Mike Fincke, Japanese astronaut Kimiya Yui and cosmonaut Oleg Platonov. Also on board: Soyuz MS-27/73S commander Sergey Ryzhikov, Alexey Zubritsky and NASA astronaut Jonny Kim. McClain and her crewmates spent four days showing the new crew the ins and outs of space station operation before bidding them farewell and undocking on Friday. Crew 10 was the first NASA-sponsored crew to land in the Pacific Ocean. All previous NASA Crew Dragon flights ended with splashdowns off the Florida coast. But SpaceX recently decided to change landing locales to make sure any debris from the Crew Dragon's no-longer-needed trunk section, discarded shortly before re-entry, splashes harmlessly into the Pacific, well away from any populated areas. Two commercial Crew Dragon flights landed in the Pacific earlier this year to pave the way for Crew 10.

FDA official returns to agency after Loomer-led ouster
FDA official returns to agency after Loomer-led ouster

CNN

time18 minutes ago

  • CNN

FDA official returns to agency after Loomer-led ouster

Dr. Vinay Prasad, a controversial critic of the US Food and Drug Administration who took a top role at the regulatory agency in May, has returned to his job weeks after resigning amid pressure from the White House and right-wing activist Laura Loomer. 'At the FDA's request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' said Health and Human Services spokesperson Andrew Nixon in a statement to CNN on Saturday. Nixon did not respond to CNN's inquiry about whether Prasad will also return to his role as FDA chief medical and scientific officer. In late July, Prasad, a hematologist oncologist, said he was resigning because he 'did not want to be a distraction to the great work of the FDA' and had 'decided to return to California and spend more time with his family.' Prasad's departure came amid fresh pressure from the White House for him to resign, according to a person familiar with the matter who was granted anonymity to describe the internal dynamics, and followed days of criticism from Loomer, who has extraordinary access to President Donald Trump. Loomer had taken shots at Prasad on her website and on social media, attacking him publicly for days as a 'progressive leftist saboteur' who was 'undermining President Trump's FDA.' Loomer focused on Prasad's previous social media posts and podcast episodes, where she said he aligned himself politically with liberal politicians and expressed 'disdain' for Trump. Her posts were followed by others from figures including former US Sen. Rick Santorum, who called Prasad 'the man destroying @POTUS legacy for helping patients,' and a Wall Street Journal opinion piece headlined, 'Vinay Prasad Is a Bernie Sanders Acolyte in MAHA Drag.' Prasad had been a vocal critic of some of the agency's drug approvals, as well as the government's response and vaccine policies during the Covid-19 pandemic. Loomer, reacting to the news of Prasad's return in a Saturday post on X, called it an 'egregious personnel decision' and said she planned to '(ramp) up my exposes of officials within HHS and FDA' in the coming weeks. Prasad also drew criticism from former officials and vaccine experts after internal memos from May revealed that he overrode FDA scientists on recommendations for two new versions of Covid-19 vaccines. The then-CBER director rebuked recommendations for broad use of the shots; the FDA eventually approved the vaccines for use in older and immunocompromised people but did not advise them for younger Americans who don't have underlying conditions. CNN's Meg Tirrell, Sarah Owermohle, and Adam Cancryn contributed to this report.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store